EPO Patents = 2

Forward Citations = 2

Loading Chart...

3 inventors (with patents filed for the assignee):

Fabienne Vernejoul (3 out of 9 patents)

Gerard Tiraby (3 out of 11 patents)

Thierry Lioux (3 out of 8 patents)

4. Gérard Tiraby (2 patents)

3 patents: Sort by Forward Citations

1. 11667664 - Cyclic dinucleotides for cytokine induction (2023-06-06),

2. 11053272 - Cyclic dinucleotides for cytokine induction (2021-07-06),

3. 10562929 - Cyclic dinucleotides for cytokine induction (2020-02-18),

Kayla Therapeutics is a biopharmaceutical company focused on developing innovative therapies for a range of diseases. Our mission is to improve the lives of patients by delivering groundbreaking treatments that address unmet medical needs. With a dedicated team of researchers and scientists, we are committed to advancing the field of biotechnology and transforming the way healthcare is delivered.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

3 Patents

#3 in L'Union

#3,968 in France

L'Union, France

Kayla Therapeutics

Forward Citations = 2

3 inventors:

Fabienne Vernejoul (3 out of 9 patents)

Gerard Tiraby (3 out of 11 patents)

Thierry Lioux (3 out of 8 patents)

4. Gérard Tiraby (2 patents)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com